The National Breast Cancer Coalition (NBCC), a lobbying group to influence the disease, is known for his skeptical approach, scientific struggling against cancer. In the early 190s, the group lobbied to create a research program of the Department of Defense Breast Cancer now funded at $ 150 million per year. Earlier this month, President outspoken NBCC lawyer Fran Visco, seemed out against the approval of Avastin for breast cancer, arguing that "it does not show a clinical benefit."
So it came as a surprise when NBCC announced this week a rather scientific sounding goal: to end breast cancer in 2020.
the deadline brings to mind a plan National cancer Institute in the early 00s to eliminate suffering and death from cancer in 2015, a goal that brought ridicule to the man behind it, can NCI Director Andrew von Eschenbach. the scientists called deadline unrealistic and fear it would undermine the credibility of NCI. Visco says the newsletter based in Washington DC, Letter cancer (subscription required) that the deadline of his group is different because unlike NCI, they want to change as usual. They succeed, after 2020, "I travel in Tuscany," she told the newsletter.
Science Insider was curious how NBCC proposes to end in breast cancer, as the website notes, no one knows how to prevent the disease. a white paper is scarce on details, except for an idea vaccine against the preventive breast cancer that 2020 campaign NBCC chose as his first project. According to a report in Nature Medicine in May such an experimental vaccine has prevented breast cancer in mouse models. the vaccine targets a protein produced by nursing mothers, so it could only be given to women of childbearing age past.
0 Komentar